Abogen Biosciences
A discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD4.3—6.5b (Dealroom.co estimates Aug 2021.)
Suzhou Shi Jiangsu (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | N/A | Angel |
* | N/A | N/A | Seed |
CNY150m | Series A | ||
CNY600m | Series B | ||
$700m | Series C | ||
Total Funding | AUD1.2b |
Related Content
Recent News about Abogen Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.